Certificate of Analysis available for every lot≥99% purity, HPLC & mass-spec verifiedFor research use only. Not for human consumption.Retatrutide is a synthetic peptide studied as a triple agonist of the GLP-1, GIP and glucagon receptors. Because it acts at all three incretin-family receptors, it is used in research on how those pathways interact in energy balance and glucose handling.
Molecular Formula: C62H98N16O22
Molecular Weight: 1419.556 g/mol
Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
CAS #: 137525-51-0
Purity: 99% HPLC
Studied in cell, animal and clinical-literature contexts around combined incretin and glucagon receptor signaling, gastric emptying, and energy expenditure pathways.
The GLP-1 receptor is associated with slowed gastric emptying and appetite signaling. The GIP receptor is associated with insulin-related signaling. The glucagon receptor is found mainly in the liver and is associated with energy expenditure pathways, including a described link to FGF21.
Published pharmacology describes full agonism at all three receptors and delayed gastric emptying that is attributed to the GLP-1 receptor component. Phase 2 trial reports are in the reference list below.
Supplied as a lyophilized powder. Identity and purity are normally confirmed by HPLC and mass spectrometry. Refer to the Certificate of Analysis for the lot you receive.
Peptides are shipped lyophilized (freeze-dried), a state that keeps them stable in transit. Keep vials cold and away from light on arrival.
Young Body supplies research compounds exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.
